Long-Term Outcome After Upgrade to Cardiac Resynchronization Therapy: A Propensity Score-Matched Analysis
Authors:
- 9 November 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 26 (2) , 511-520
Abstract
Aim: Cardiac resynchronization therapy (CRT) is a cornerstone in the management of chronic heart failure in patients with a broad or paced QRS. However, data on long-term outcome after upgrade to CRT are scarce. Methods and results: This international, multicentre retrospective registry included 2275 patients who underwent a de novo or upgrade CRT implantation with a mean follow-up of 3.6 ± 2.7 years. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. Multivariable Cox regression and propensity score matching (PSM) analyses were performed. Patients who underwent CRT upgrade (n = 605, 26.6%) were less likely female (19.7% vs. 28.8%, p < 0.001), more often had ischeemic cardiomyopathy (49.8% vs. 40.2%, p < 0.001), and had worse renal function (median estimated glomerular filtration rate 50.3 ml/min/1.73 m2 [35.8–69.5] vs. 59.9 ml/min/1.73 m2 [43.0–76.5], p < 0.001). The incidence rate of the composite endpoint was 10.8%/year after CRT upgrade versus 7.1%/year for de novo implantations (p < 0.001). PSM for the primary endpoint resulted in 488 pairs. After propensity score matching, upgrade to CRT was associated with a higher chance to reach the composite endpoint (multivariable hazard ratio [HR] 1.35, 95% confidence interval [CI] 1.08–1.70), for both upgrade from pacemaker (multivariable HR 1.33, 95% CI 1.03–1.70) and implantable cardioverter-defibrillator (ICD) (multivariable HR 1.40, 95% CI 1.01–1.95). PSM for the secondary endpoint resulted in 277 pairs. After PSM, upgrade to CRT was associated with a higher chance for heart failure admission (HR 1.74, 95% CI 1.26–2.41). Conclusion: In this retrospective analysis, the outcome of patients who underwent upgrades to CRT differed significantly from patients who underwent de novo CRT implantation, particularly for upgrades from ICD. Importantly, this difference in outcome does not imply a causal relation between therapy and outcome but rather a difference between two different patient populations.Keywords
This publication has 26 references indexed in Scilit:
- Long-Term Outcome After CRT in the Presence of Mechanical Dyssynchrony Seen With Chronic RV Pacing or Intrinsic LBBBJACC: Cardiovascular Imaging, 2017
- Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003–2013Heart Rhythm, 2017
- Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term SurvivalCirculation: Arrhythmia and Electrophysiology, 2017
- Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy PatientsPacing and Clinical Electrophysiology, 2016
- Time to left ventricular reverse remodeling after cardiac resynchronization therapy: Better late than neverRevista Portuguesa de Cardiologia, 2016
- Echocardiographic and Clinical Response to Cardiac Resynchronization Therapy in Heart Failure Patients with and without Previous Right Ventricular PacingEuropean Journal of Heart Failure, 2014
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyEuropean Heart Journal, 2013
- The European Cardiac Resynchronization Therapy Survey: Comparison of Outcomes between De Novo Cardiac Resynchronization Therapy Implantations and UpgradesEuropean Journal of Heart Failure, 2011
- Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodellingEuropean Heart Journal, 2010
- Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failureEP Europace, 2008